According to a recent report by medicalnews.com, a phase II clinical trial is being conducted by Aquinox Pharmaceuticals for its drug AQX-1125 for bladder pain syndrome. The research study is being conducted in Canada and is targeted to end by late 2014. Bladder pain syndrome/interstitial cystitis (BPS/IC) happens to millions of people, especially women around the globe. Currently there are no effective therapies to completely cure the disease, but rather reduce the symptoms.
Please join Reg4All and be a part of the health registry.